EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma

Deborah W Knapp, Audrey Ruple-Czerniak, José A Ramos-Vara, James F Naughton, Christopher M Fulkerson, Sonia I Honkisz

Bladder Cancer · 02.04.2016 · 2 (2) · 241-250

DOI: 10.3233/blc-150044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bladder Cancer, online erschienen am 02.04.2016. Verfasst von Deborah W Knapp und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, IN, USA; Purdue University Center for Cancer Research, Purdue Universi…. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy is expected to remain an important part of invasive urothelial carcinoma (UC) treatment. Strategies to enhance chemotherapy efficacy are needed.

Objective

To determine the chemotherapy-enhancing effects of a nonselective cyclooxygenase (COX) inhibitor on vinblastine in a naturally-occurring canine model of invasive UC.

Methods

With IACUC approval, privately-owned dogs with naturally-occurring histologically-diagnosed invasive UC, expected survival ≥6 weeks, and informed owner consent were randomly allocated to receive vinblastine (2.5 mg/m 2 intravenously every 2 weeks) plus piroxicam (0.3 mg/kg daily per os) or vinblastine alone (same dose) with the option to receive piroxicam alone when vinblastine failed. Scheduled evaluations included physical exam, standard laboratory analyses, thoracic radiography, abdominal ultrasonography, and standardized measurement of urinary tract tumors.

Results

Dogs receiving vinblastine alone ( n = 27) and vinblastine-piroxicam ( n = 24) were similar in age, sex, breed, tumor stage, and grade. Remission occurred more frequently ( P < 0.02) with vinblastine-piroxicam (58.3%) than with vinblastine alone (22.2%). The median progression free interval was 143 days with vinblastine alone and 199 days with the combination. Interestingly, the overall median survival time was significantly longer ( P < 0.03) in dogs receiving vinblastine alone followed by piroxicam alone ( n = 20, 531 days) than in dogs receiving the combination (299 days). Treatment was well tolerated in both arms.

Conclusions

Piroxicam significantly enhanced the activity of vinblastine in dogs with UC where the cancer closely mimics the human condition, clearly justifying further study. The study suggest the potential importance of tracking COX inhibitor use in patients in clinical trials as COX inhibitors could affect treatment response.

Schlagwörter

Stichwörter der Autor:innen

Urinary bladder canceranimal modelscyclooxygenase inhibitordogpiroxicamtransitional cell carcinomaurothelial carcinomavinblastine

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, Purdue University, West Lafayette, IN, USA; Purdue University Center for Cancer Research, Purdue University, West Lafayette, IN, USA.
  • Department of Comparative Pathobiology, Purdue University , West Lafayette, IN, USA.
  • Indiana Veterinary Imaging, Indianapolis, IN, USA.
  • Department of Veterinary Clinical Sciences, Purdue University , West Lafayette, IN, USA.

Zitieren

APA

Knapp, D. W., Ruple-Czerniak, A., Ramos-Vara, J. A., Naughton, J. F., Fulkerson, C. M., & Honkisz, S. I. (2016). A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma. Bladder Cancer, 2(2), 241-250. https://doi.org/10.3233/blc-150044

Vancouver

Knapp DW, Ruple-Czerniak A, Ramos-Vara JA, Naughton JF, Fulkerson CM, Honkisz SI. A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma. Bladder Cancer. 2016;2(2):241-250. doi:10.3233/blc-150044

BibTeX
@article{Knapp2016,
  author = {Knapp, Deborah W and Ruple-Czerniak, Audrey and Ramos-Vara, José A and Naughton, James F and Fulkerson, Christopher M and Honkisz, Sonia I},
  title = {A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma},
  journal = {Bladder Cancer},
  year = {2016},
  volume = {2},
  number = {2},
  pages = {241--250},
  doi = {10.3233/blc-150044}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche